Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 2/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12724727 | 0.92 | TYMP (0.46) | TYMPSLC29A1ADORA1 | |
| SCHEMBL13930532 | 0.92 | TYMP (0.46) | TYMPSLC29A1ADORA1 | |
| SCHEMBL13897165 | 0.92 | TYMP (0.46) | TYMPSLC29A1ADORA1 | |
| SCHEMBL16417871 | 0.92 | TYMP (0.42) | TYMPSLC29A1ADORA1ADORA3ADORA2B | |
| SCHEMBL13897137 | 0.92 | TYMP (0.40) | TYMPSLC29A1ADORA1ADORA3ADORA2B | |
| SCHEMBL12724731 | 0.92 | TYMP (0.40) | TYMPSLC29A1ADORA1ADORA3ADORA2B | |
| SCHEMBL13930543 | 0.91 | TYMP (0.42) | TYMPSLC29A1ADORA1ADORA3ADORA2B | |
| SCHEMBL13951916 | 0.91 | TYMP (0.42) | TYMPSLC29A1ADORA1ADORA3ADORA2B | |
| SCHEMBL13375793 | 0.90 | ADORA1 (0.36) | TYMPADORA1ADORA3ADORA2B | |
| SCHEMBL12724728 | 0.88 | TYMP (0.50) | TYMPSLC29A1ADORA1ADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353142-B2 | Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method | APTA BIOSCIENCES LTD. (GB) | 2016-05-31 | — | — | US | disclosed |
| US-20140256928-A1 | PROTECTING GROUP FOR INDOLE GROUP, NUCLEIC ACID-SYNTHESIZING AMIDITE AND NUCLEIC ACID-SYNTHESIZING METHOD | APTA BIOSCIENCES LTD. (GB) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256928-A1 | PROTECTING GROUP FOR INDOLE GROUP, NUCLEIC ACID-SYNTHESIZING AMIDITE AND NUCLEIC ACID-SYNTHESIZING METHOD | INMT, NSUN2, RNMT | TYMP 464/4885SLC29A1 447/4885ADORA1 555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.